New hope for lung cancer: LIBRA trial tests smart drug cocktails

NCT ID NCT07098338

Recruiting now Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated Jun 14, 2026 · Updated 30 times

Summary

This study tests several new drug combinations in people with advanced non-small cell lung cancer that has spread. The goal is to see if these combinations are safe and can shrink tumors. About 278 adults will take part across 10 countries. The study is open to those with a specific protein marker (PD-L1 ≥1%) and who have not had prior treatment for advanced disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Research Site
NOT_YET_RECRUITING

Santa Monica, California, 90404, United States
Research Site
NOT_YET_RECRUITING

Santa Rosa, California, 95403, United States
Research Site
RECRUITING

Atlanta, Georgia, 30318, United States
Research Site
NOT_YET_RECRUITING

Baltimore, Maryland, 21231, United States
Research Site
NOT_YET_RECRUITING

Houston, Texas, 77090, United States
Research Site
RECRUITING

Fairfax, Virginia, 22031, United States
Research Site
NOT_YET_RECRUITING

Heidelberg, 3084, Australia
Research Site
NOT_YET_RECRUITING

Nedlands, 6009, Australia
Research Site
NOT_YET_RECRUITING

Woodville, 5011, Australia
Research Site
NOT_YET_RECRUITING

Toronto, Ontario, M5G 2M9, Canada
Research Site
RECRUITING

Changsha, 410013, China
Research Site
RECRUITING

Chengdu, 610041, China
Research Site
RECRUITING

Deyang, 618000, China
Research Site
RECRUITING

Dongguan, 523059, China
Research Site
WITHDRAWN

Fuzhou, 350014, China
Research Site
RECRUITING

Guangzhou, 510080, China
Research Site
RECRUITING

Guangzhou, 510100, China
Research Site
RECRUITING

Hangzhou, 310014, China
Research Site
RECRUITING

Hefei, 230022, China
Research Site
RECRUITING

Linyi, 276001, China
Research Site
RECRUITING

Mianyang, 621000, China
Research Site
RECRUITING

Nanchang, 330000, China
Research Site
RECRUITING

Nanchang, 330006, China
Research Site
RECRUITING

Shantou, China
Research Site
RECRUITING

Shenyang, 110042, China
Research Site
RECRUITING

Wuhan, 430022, China
Research Site
RECRUITING

Zhengzhou, 450000, China
Research Site
RECRUITING

Zhengzhou, 450008, China
Research Site
RECRUITING

Zhuhai, 519000, China
Research Site
NOT_YET_RECRUITING

Avignon, 84902, France
Research Site
NOT_YET_RECRUITING

Paris, 75005, France
Research Site
NOT_YET_RECRUITING

Rennes, 35000, France
Research Site
NOT_YET_RECRUITING

Saint-Herblain, 44805, France
Research Site
NOT_YET_RECRUITING

Suresnes, 92150, France
Research Site
NOT_YET_RECRUITING

Aviano, 33081, Italy
Research Site
NOT_YET_RECRUITING

Catania, 95123, Italy
Research Site
NOT_YET_RECRUITING

Meldola, 47014, Italy
Research Site
NOT_YET_RECRUITING

Milan, 20141, Italy
Research Site
NOT_YET_RECRUITING

Milan, 35128, Italy
Research Site
NOT_YET_RECRUITING

Orbassano, 10043, Italy
Research Site
NOT_YET_RECRUITING

Roma, 00144, Italy
Research Site
NOT_YET_RECRUITING

Rozzano, 20089, Italy
Research Site
RECRUITING

Bunkyō City, 113-8677, Japan
Research Site
RECRUITING

Fukuyama-shi, 722-0001, Japan
Research Site
RECRUITING

Kobe, 650-0047, Japan
Research Site
RECRUITING

Kurume-shi, 830-0011, Japan
Research Site
RECRUITING

Kyoto, 602-8566, Japan
Research Site
RECRUITING

Kyoto, 606-8507, Japan
Research Site
RECRUITING

Osaka, 541-8567, Japan
Research Site
RECRUITING

Sakaishi, 591-8555, Japan
Research Site
RECRUITING

Shinjuku-ku, 162-8655, Japan
Research Site
RECRUITING

Wakayama, 641-8510, Japan
Research Site
RECRUITING

Yokohama, 236-0051, Japan
Research Site
RECRUITING

Singapore, 119082, Singapore
Research Site
RECRUITING

Singapore, 168583, Singapore
Research Site
RECRUITING

Cheongju-si, 28644, South Korea
Research Site
RECRUITING

Namdong-gu, 21565, South Korea
Research Site
RECRUITING

Seongnam-si, 13496, South Korea
Research Site
RECRUITING

Seoul, 03080, South Korea
Research Site
RECRUITING

Seoul, 06351, South Korea
Research Site
RECRUITING

Seoul, 3722, South Korea
Research Site
RECRUITING

Seoul, 5505, South Korea
Research Site
RECRUITING

Suwon, 16247, South Korea
Research Site
RECRUITING

Suwon, 16499, South Korea
Research Site
NOT_YET_RECRUITING

A Coruña, 15006, Spain
Research Site
NOT_YET_RECRUITING

Madrid, 28041, Spain
Research Site
NOT_YET_RECRUITING

Manresa, 08243, Spain
Research Site
NOT_YET_RECRUITING

Málaga, 29009, Spain
Research Site
NOT_YET_RECRUITING

Santander, 39008, Spain
Research Site
NOT_YET_RECRUITING

Valencia, 46010, Spain
Research Site
RECRUITING

Liuying, 736, Taiwan
Research Site
RECRUITING

Taichung, 402, Taiwan
Research Site
RECRUITING

Taichung, 40447, Taiwan
Research Site
RECRUITING

Tainan, 70403, Taiwan
Research Site
RECRUITING

Tainan, 710, Taiwan
Research Site
RECRUITING

Taipei, 100, Taiwan
Research Site
RECRUITING

Taipei, 110, Taiwan
Research Site
RECRUITING

Taipei, 11217, Taiwan
Research Site
RECRUITING

Taoyuan, 00333, Taiwan
Research Site
NOT_YET_RECRUITING

Bangkok, 10330, Thailand
Research Site
NOT_YET_RECRUITING

Bangkok, 10400, Thailand
Research Site
NOT_YET_RECRUITING

Bangkok, 10700, Thailand
Research Site
NOT_YET_RECRUITING

Banphaeo, 74120, Thailand

Conditions

The condition(s) this trial relates to.

non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NON SMALL CELL LUNG CANCER NON-SMALL CELL LUNG CANCER